These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28759960)
1. Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis. Fu L; Liu S; Wang H; Ma Y; Li L; He X; Mou X; Tong X; Hu Z; Ru G Cancer Biomark; 2017 Jul; 20(1):101-106. PubMed ID: 28759960 [TBL] [Abstract][Full Text] [Related]
2. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma. Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574 [TBL] [Abstract][Full Text] [Related]
3. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study. Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736 [TBL] [Abstract][Full Text] [Related]
4. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy. Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035 [TBL] [Abstract][Full Text] [Related]
5. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179 [TBL] [Abstract][Full Text] [Related]
6. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma. Zeng L; Fan X; Wang X; Deng H; Zhang X; Zhang K; He S; Li N; Han Q; Liu Z BMC Med Genomics; 2020 Oct; 13(1):158. PubMed ID: 33109182 [TBL] [Abstract][Full Text] [Related]
7. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma. Lin S; Zhou S; Jiang S; Liu X; Wang Y; Zheng X; Zhou H; Li X; Cai X Oncol Rep; 2016 Aug; 36(2):853-62. PubMed ID: 27349376 [TBL] [Abstract][Full Text] [Related]
8. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition. Zhang Y; Wang W; Wang Y; Huang X; Zhang Z; Chen B; Xie W; Li S; Shen S; Peng B Oncol Rep; 2018 Mar; 39(3):1023-1033. PubMed ID: 29399700 [TBL] [Abstract][Full Text] [Related]
9. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation. Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921 [TBL] [Abstract][Full Text] [Related]
10. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo. Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma. Liu H; Liu B; Hou X; Pang B; Guo P; Jiang W; Ding Q; Zhang R; Xin T; Guo H; Xu S; Pang Q J Neurooncol; 2017 May; 132(3):409-417. PubMed ID: 28321704 [TBL] [Abstract][Full Text] [Related]
12. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma. Huang W; Cui X; Chen Y; Shao M; Shao X; Shen Y; Liu Q; Wu M; Liu J; Ni W; Lu C; Wan C Pathol Res Pract; 2016 Mar; 212(3):171-8. PubMed ID: 26706601 [TBL] [Abstract][Full Text] [Related]
13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma. Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
17. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance and prognostic value of Nek2 protein expression in colon cancer. Lu L; Zhai X; Yuan R Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer. Zeng YR; Han ZD; Wang C; Cai C; Huang YQ; Luo HW; Liu ZZ; Zhuo YJ; Dai QS; Zhao HB; Liang YX; Zhong WD BMC Urol; 2015 Aug; 15():90. PubMed ID: 26320076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]